Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trifluridine/Tipiracil Plus Oxaliplatin in Advanced Biliary Tract Cancer
NCT07146646Phase 2Suspended
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Dec 2025
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trifluridine + tipiracil in biliary tract cancer (BTC), sponsored by Case Comprehensive Cancer Center. Started Dec 2025; status: suspended.
02
Drugs
trifluridine + tipiracil
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT07146646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07146646.